DMPV
Delphi Management Partners VIII Portfolio holdings
AUM
$138M
This Quarter Return
+2.11%
1 Year Return
+56.76%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$152M
AUM Growth
–
Cap. Flow
+$152M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Tandem Diabetes Care
TNDM
|
$95.7M |
| 2 |
Karyopharm Therapeutics
KPTI
|
$35M |
| 3 |
CALA
Calithera Biosciences, Inc
CALA
|
$11.9M |
| 4 |
Senseonics Holdings
SENS
|
$8.59M |
| 5 |
MREO
Mereo BioPharma
MREO
|
$919K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 86.52% |
| 2 | Technology | 5.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tandem Diabetes Care
TNDM
$834M
| $95.7M | 62.89% |
+1,000,000
| New | +$95.7M |
|
|
2
Karyopharm Therapeutics
KPTI
$61.4M
| $35M | 23.03% |
+2,263,006
| New | +$35M |
|
|
CALA
3
DELISTED
Calithera Biosciences, Inc
CALA
| $11.9M | 7.83% |
+2,426,702
| New | +$11.9M |
|
|
4
Senseonics Holdings
SENS
$368M
| $8.59M | 5.64% |
+9,846,294
| New | +$8.59M |
|
|
MREO
5
Mereo BioPharma
MREO
$275M
| $919K | 0.6% |
+256,734
| New | +$919K |
|